Table 3:
Associations of RA-related autoantibodies with isolated RA-bronchiectasis
| RA-related autoantibody status* |
Multivariable†OR for isolated RA-BR (95%CI) |
p-value |
|---|---|---|
| RF negative | 1.00 (Ref) | |
| RF positive (>1x ULN) | 4.40 (2.14-9.07) | <0.0001 |
| RF negative | 1.00 (Ref) | |
| RF low-positive (>1-3x ULN) | 1.95 (0.67-5.66) | 0.22 |
| RF high-positive (>3x ULN) | 5.44 (2.57-11.54) | <0.0001 |
| Anti-CCP negative | 1.00 (Ref) | |
| CCP positive (>1x ULN) | 3.47 (1.65-7.31) | 0.001 |
| Anti-CCP negative | 1.00 (Ref) | |
| Anti-CCP low-positive (>1-3x ULN) | 1.45 (0.29-7.32) | 0.65 |
| Anti-CCP high-positive (>3x ULN) | 3.73 (1.76-7.90) | 0.0006 |
RF analyses included 53 cases and 352 controls (n=12 missing RF status); anti-CCP analyses included 44 cases and 320 controls (n=53 missing anti-CCP status)
Adjusted for age, sex, race, RA duration, smoking status, pack-years, and body mass index anti-CCP = anti-cyclic citrullinated peptide; BR = bronchiectasis; CI = confidence interval; OR = odds ratio; RA = rheumatoid arthritis; RF = rheumatoid factor; ULN = upper limit of normal